Publication Name	World Journal of Gastroenterology
Manuscript ID	80280
Country	Taiwan

Received	2022-09-30 07:36
Peer-Review Started	2022-09-30 07:39
First Decision by Editorial Office Director	2022-11-17 03:12
Return for Revision	2022-11-17 03:12
Revised	2022-11-18 13:51
Publication Fee Transferred
Second Decision by Editor	2022-12-20 08:13
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director	2022-12-21 03:42
Articles in Press	2022-12-21 03:42
Edit the Manuscript by Language Editor
Typeset the Manuscript	2022-12-21 08:31
Publish the Manuscript Online	2023-01-12 10:19

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Rheumatology
Manuscript Type	Review
Article Title	Seronegative spondyloarthropathy-associated inflammatory bowel disease
Manuscript Source	Invited Manuscript
All Author List	Chrong-Reen Wang and Hung-Wen Tsai
ORCID	Author(s) ORCID Number Chrong-Reen Wang http://orcid.org/0000-0001-9881-7024 Hung-Wen Tsai http://orcid.org/0000-0001-9223-2535
Funding Agency and Grant Number
Corresponding Author	Chrong-Reen Wang, MD, PhD, Full Professor, Department of Internal Medicine, National Cheng Kung University Hospital, No. 138 Sheng-Li Road, Tainan 70403, Taiwan. wangcr@mail.ncku.edu.tw
Key Words	Seronegative spondyloarthropathy; Inflammatory bowel disease; Biologics; Anti-tumor necrosis factor monoclonal antibody; Small molecules; Janus kinases inhibitor
Core Tip	Seronegative spondyloarthropathy (SpA) with negative rheumatoid factor has spinal and peripheral arthritis, dactylitis, enthesitis and extra-articular manifestations (EAMs). It can be classified into ankylosing spondylitis, psoriatic arthritis, reactive arthritis, enteropathic arthritis, and juvenile-onset spondyloarthritis. Inflammatory bowel disease (IBD) is a common EAM in SpA, whereas extraintestinal manifestations in IBD mostly affect the joints. Anti-tumor necrosis factor monoclonal antibodies are effective medications with indicated use in SpA and IBD, a drug of choice for treating SpA-associated IBD. A tight collaboration between gastroenterologists and rheumatologists with mutual referral from early accurate diagnosis to prompt therapy is required in this complex clinical scenario.
Publish Date	2023-01-12 10:19
Citation	Wang CR, Tsai HW. Seronegative spondyloarthropathy-associated inflammatory bowel disease. World J Gastroenterol 2023; 29(3): 450-468
URL	https://www.wjgnet.com/1007-9327/full/v29/i3/450.htm
DOI	https://dx.doi.org/10.3748/wjg.v29.i3.450

Full Article (PDF)	WJG-29-450.pdf
Full Article (Word)	WJG-29-450.docx
Manuscript File	80280_Auto_Edited-XML.docx
Answering Reviewers	80280-Answering reviewers.pdf
Audio Core Tip	80280-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	80280-Conflict-of-interest statement.pdf
Copyright License Agreement	80280-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	80280-Language certificate.pdf
Peer-review Report	80280-Peer-review(s).pdf
Scientific Misconduct Check	80280-Bing-Chen YL-2.png
Scientific Editor Work List	80280-Scientific editor work list.pdf
CrossCheck Report	80280-CrossCheck report.pdf